Clinical Trial Update: A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating elritercept to treat anemia in adults with very low to intermediate-risk myelodysplastic syndromes who require regular blood transfusio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Elritercept (Elritercept)

Snippet

Sponsor: Takeda | Conditions: Myelodysplastic Syndromes | Phase 3 | Status: RECRUITING